NCT06848231 - A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Multiple System Atrophy

Interventions

DRUG

YA-101

"Drug: YA-101~• YA-101 taken BID"

DRUG

Placebo

Placebo taken BID

Trial Locations (9)

106

NOT_YET_RECRUITING

National Taiwan University Hospital Cancer Center, Taipei

10032

RECRUITING

Columbia University Irving medical center, New York

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

55905

RECRUITING

Mayo Clinic, Rochester

77030

RECRUITING

Baylor College of Medicine, Houston

90095

RECRUITING

UCLA Health, Los Angeles

100225

RECRUITING

National Taiwan University Hospital, Taipei

02115

RECRUITING

Brigham and Women's Hospital, Boston

Unknown

RECRUITING

Juntendo University Hospital, Tokyo

All Listed Sponsors

lead

Yoda Therapeutics Inc.

INDUSTRY